v3.26.1
MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIT (Tables)
 3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Common Stock Reserved for Future Issuance
The following shares of common stock are reserved for future issuance (in whole shares):
March 31, 2026December 31, 2025
Exercise of stock options and settlement of RSUs1
16,035,09814,480,386
Issuance of warrants5,257,5795,304,255
Issuance of preferred stock68,987,98867,992,679
90,280,66587,777,320
_______________
(1)The December 31, 2025 balance has been adjusted from previously reported amounts to reflect an immaterial reduction of 377,671 options. This adjustment did not have a material impact on the Company's previously issued consolidated financial statements or share-based compensation expense.
Schedule of Convertible Preferred Stock
The Company is authorized to issue 77,003,772 shares of Convertible Preferred Stock with a $0.0001 par value as follows (in whole shares):
March 31, 2026December 31, 2025
Series A-17,312,5007,312,500
Series A-212,680,90812,680,908
Series A-34,953,7464,953,746
Series B11,574,84111,574,841
Series C6,960,4396,960,439
Series D12,857,72012,857,720
Series D-16,085,1616,085,161
Series E14,578,45714,578,457
Total77,003,77277,003,772
The following table represents the total issued and outstanding Preferred Stock of the Company as of March 31, 2026 and December 31, 2025 (in whole shares):
March 31,
2026		December 31,
2025
Series A-17,312,5007,312,500
Series A-212,680,90812,680,908
Series A-34,953,7464,953,746
Total Series A24,947,15424,947,154
Total Series B11,574,84111,574,841
Total Series C6,960,4396,960,439
Total Series D12,857,72012,857,720
Total Series D-16,085,1616,085,161
Total Series E6,562,6735,567,364
Summary of Warrants Outstanding
The following is a summary of the warrants outstanding in connection with the Series C Preferred Stock, Series D Preferred Stock, Series D-1 Preferred Stock, and Series E Preferred Stock financings as of March 31, 2026 (in whole dollars and shares):
Expiration Date
Exercise Price
Series C
Series D
Series D-1
Total
May 2031
$0.0190,044——90,044
June 2031
$0.01220,074——220,074
November 2031
$0.01—1,749,025—1,749,025
December 2031
$0.01—72,376—72,376
July 2033
$0.01——2,072,6652,072,665
July 2033
$11.17——252,116252,116
September 2033
$0.01——164,319164,319
September 2033
$11.17——43,46943,469
310,1181,821,4012,532,5694,664,088
As of March 31, 2026, the following equity and debt classified warrants to issue stock of the Company remain outstanding:
Original Issuance DateExpiration DateExercise PriceWarrants
Issued		Warrants
Currently
Exercisable
June 2017June 2027$0.2347,70047,700
May 2018June 2027$0.2315,90015,900
May 2019March 2029$0.7725,42825,428
May 2019March 2029$0.7725,42925,429
February 2020February 2032$2.29112,240112,240
February 2020February 2032$2.29112,240112,240
February 2020February 2032$2.2956,12056,120
March 2024March 2034$2.3164,99864,998
December 2025December 2035$4.65173,591173,591
633,646633,646